ResMed Inc.’s Stock Price Takes a Dip to $223.83, Marking a 3.30% Decrease: Is it Time to Buy?

ResMed Inc. (RMD)

223.83 USD -7.65 (-3.30%) Volume: 1.19M

ResMed Inc.’s stock price stands at 223.83 USD, experiencing a dip of -3.30% this trading session with a trading volume of 1.19M. Despite the recent downturn, the stock’s year-to-date (YTD) percentage change is only -2.13%, showcasing the resilience of RMD in the market.

Latest developments on ResMed Inc.

ResMed Inc stock has been on the rise, climbing 25.6% in the past year. Analysts at Stifel recently adjusted their price target on ResMed to $240, down from $250, while maintaining a Hold rating. This comes amidst reports of changes in beneficial ownership and stock transactions by ResMed executives. Additionally, concerns about the CPAP market led Stifel to lower their price target. Despite this, ResMed shares were added to Goldman’s Conviction List, showing continued confidence in the company’s future. With global growth in the ventilators market and ongoing stock movements, investors are closely watching ResMed Inc for potential opportunities.

ResMed Inc. on Smartkarma

Analysts at Baptista Research have provided bullish coverage of ResMed Inc on Smartkarma, highlighting the company’s strong financial performance in their second quarter fiscal year 2025 earnings presentation. The global revenue of ResMed Inc saw a 10% increase, reaching $1.28 billion, with growth in device sales and masks and accessories by 11% each. This growth reflects the company’s strategic initiatives and positive market outlook.

Another report by Baptista Research on Smartkarma focuses on ResMed Inc’s expansion of patient access and engagement through technology to drive growth. The company’s Q1 Fiscal Year 2025 earnings report showcased a robust start to the year, with an 11% revenue increase attributed to strong demand for sleep health products and software offerings. Baptista Research evaluates various factors influencing the company’s future stock price and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.

A look at ResMed Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Resmed Inc has a positive long-term outlook. With high scores in Growth and Momentum, the company is positioned for future expansion and market success. Its focus on developing and marketing medical equipment for sleep disordered breathing treatment sets it apart in the healthcare industry.

Although Resmed Inc scores lower in Value and Dividend, its overall Resilience score indicates a stable foundation for weathering economic uncertainties. Investors looking for a company with strong growth potential and market momentum may find Resmed Inc to be a promising choice for long-term investment.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma